Loading…
Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity
Bacillus anthracis, the causative agent of anthrax, is a Gram-positive, spore-forming bacterium. B. anthracis virulence is ascribed mainly to a secreted tripartite AB-type toxin composed of three proteins designated protective Ag (PA), lethal factor, and edema factor. PA assembles with the enzymatic...
Saved in:
Published in: | Journal of Immunology 2006-06, Vol.176 (12), p.7557-7565 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3 |
---|---|
cites | cdi_FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3 |
container_end_page | 7565 |
container_issue | 12 |
container_start_page | 7557 |
container_title | Journal of Immunology |
container_volume | 176 |
creator | Crawford, Matthew A Aylott, Caroline V Bourdeau, Raymond W Bokoch, Gary M |
description | Bacillus anthracis, the causative agent of anthrax, is a Gram-positive, spore-forming bacterium. B. anthracis virulence is ascribed mainly to a secreted tripartite AB-type toxin composed of three proteins designated protective Ag (PA), lethal factor, and edema factor. PA assembles with the enzymatic portions of the toxin, the metalloprotease lethal factor, and/or the adenylate cyclase edema factor, to generate lethal toxin (LTx) and edema toxin (ETx), respectively. These toxins enter cells through the interaction of PA with specific cell surface receptors. The anthrax toxins act to suppress innate immune responses and, given the importance of human neutrophils in innate immunity, they are likely relevant targets of the anthrax toxin. We have investigated in detail the effects of B. anthracis toxin on superoxide production by primary human neutrophils. Both LTx and ETx exhibit distinct inhibitory effects on fMLP (and C5a) receptor-mediated superoxide production, but have no effect on PMA nonreceptor-dependent superoxide production. These inhibitory effects cannot be accounted for by induction of neutrophil death, or by changes in stimulatory receptor levels. Analysis of NADPH oxidase regulation using whole cell and cell-free systems suggests that the toxins do not exert direct effects on NADPH oxidase components, but rather act via their respective effects, inhibition of MAPK signaling (LTx), and elevation of intracellular cAMP (ETx), to inhibit upstream signaling components mediating NADPH oxidase assembly and/or activation. Our results demonstrate that anthrax toxins effectively suppress human neutrophil-mediated innate immunity by inhibiting their ability to generate superoxide for bacterial killing. |
doi_str_mv | 10.4049/jimmunol.176.12.7557 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17243806</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>17243806</sourcerecordid><originalsourceid>FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3</originalsourceid><addsrcrecordid>eNpNkMtOwzAQRS0EoqXwBwhlhdikjJ3YTpalPFqpalmUteUkDnHlJCVOSPv3uGoRzGY0mnPv4iB0i2EcQhg_bnRZdlVtxpizMSZjTik_Q0NMKfiMATtHQwBCfPfmA3Rl7QYAGJDwEg0w4xSHQIZo_iRTbUxnPVm1ReMO663rna6sN68KnejWm3WlrLyl6tqm3hbaeMvJ8_vMW-10Jq3yJmmrv3W7v0YXuTRW3Zz2CH28vqynM3-xeptPJws_DVjc-jTME2BxGHGFmeJu8gArluYUIplAnMeZSmMlM06iNMlwRGTEowwTmQeERjIYoftj77apvzplW1FqmypjZKXqzgrMSRhEwBwYHsG0qa1tVC62jS5lsxcYxEGh-FXoMkxgIg4KXezu1N8lpcr-QidnDng4AoX-LHrdKGFLaYzDsej7_n_XDy0AfPw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17243806</pqid></control><display><type>article</type><title>Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity</title><source>Wiley-Blackwell Read & Publish Collection</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><creator>Crawford, Matthew A ; Aylott, Caroline V ; Bourdeau, Raymond W ; Bokoch, Gary M</creator><creatorcontrib>Crawford, Matthew A ; Aylott, Caroline V ; Bourdeau, Raymond W ; Bokoch, Gary M</creatorcontrib><description>Bacillus anthracis, the causative agent of anthrax, is a Gram-positive, spore-forming bacterium. B. anthracis virulence is ascribed mainly to a secreted tripartite AB-type toxin composed of three proteins designated protective Ag (PA), lethal factor, and edema factor. PA assembles with the enzymatic portions of the toxin, the metalloprotease lethal factor, and/or the adenylate cyclase edema factor, to generate lethal toxin (LTx) and edema toxin (ETx), respectively. These toxins enter cells through the interaction of PA with specific cell surface receptors. The anthrax toxins act to suppress innate immune responses and, given the importance of human neutrophils in innate immunity, they are likely relevant targets of the anthrax toxin. We have investigated in detail the effects of B. anthracis toxin on superoxide production by primary human neutrophils. Both LTx and ETx exhibit distinct inhibitory effects on fMLP (and C5a) receptor-mediated superoxide production, but have no effect on PMA nonreceptor-dependent superoxide production. These inhibitory effects cannot be accounted for by induction of neutrophil death, or by changes in stimulatory receptor levels. Analysis of NADPH oxidase regulation using whole cell and cell-free systems suggests that the toxins do not exert direct effects on NADPH oxidase components, but rather act via their respective effects, inhibition of MAPK signaling (LTx), and elevation of intracellular cAMP (ETx), to inhibit upstream signaling components mediating NADPH oxidase assembly and/or activation. Our results demonstrate that anthrax toxins effectively suppress human neutrophil-mediated innate immunity by inhibiting their ability to generate superoxide for bacterial killing.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>EISSN: 1365-2567</identifier><identifier>DOI: 10.4049/jimmunol.176.12.7557</identifier><identifier>PMID: 16751402</identifier><language>eng</language><publisher>United States: Am Assoc Immnol</publisher><subject>Antigens, Bacterial - immunology ; Bacillus anthracis ; Bacillus anthracis - immunology ; Bacillus anthracis - pathogenicity ; Bacterial Toxins - immunology ; Cell Survival - immunology ; Cell-Free System - immunology ; Cell-Free System - microbiology ; Cyclic AMP - biosynthesis ; Humans ; Immunosuppressive Agents - immunology ; NADPH Oxidases - antagonists & inhibitors ; NADPH Oxidases - metabolism ; Neutrophils - enzymology ; Neutrophils - metabolism ; Neutrophils - microbiology ; p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors ; p38 Mitogen-Activated Protein Kinases - metabolism ; Protein Subunits - immunology ; Reactive Oxygen Species - antagonists & inhibitors ; Reactive Oxygen Species - metabolism ; Receptors, Formyl Peptide - physiology ; Signal Transduction - immunology ; Superoxides - antagonists & inhibitors ; Superoxides - metabolism ; Tetradecanoylphorbol Acetate - pharmacology ; Up-Regulation - immunology ; Virulence Factors - immunology</subject><ispartof>Journal of Immunology, 2006-06, Vol.176 (12), p.7557-7565</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3</citedby><cites>FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16751402$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Crawford, Matthew A</creatorcontrib><creatorcontrib>Aylott, Caroline V</creatorcontrib><creatorcontrib>Bourdeau, Raymond W</creatorcontrib><creatorcontrib>Bokoch, Gary M</creatorcontrib><title>Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity</title><title>Journal of Immunology</title><addtitle>J Immunol</addtitle><description>Bacillus anthracis, the causative agent of anthrax, is a Gram-positive, spore-forming bacterium. B. anthracis virulence is ascribed mainly to a secreted tripartite AB-type toxin composed of three proteins designated protective Ag (PA), lethal factor, and edema factor. PA assembles with the enzymatic portions of the toxin, the metalloprotease lethal factor, and/or the adenylate cyclase edema factor, to generate lethal toxin (LTx) and edema toxin (ETx), respectively. These toxins enter cells through the interaction of PA with specific cell surface receptors. The anthrax toxins act to suppress innate immune responses and, given the importance of human neutrophils in innate immunity, they are likely relevant targets of the anthrax toxin. We have investigated in detail the effects of B. anthracis toxin on superoxide production by primary human neutrophils. Both LTx and ETx exhibit distinct inhibitory effects on fMLP (and C5a) receptor-mediated superoxide production, but have no effect on PMA nonreceptor-dependent superoxide production. These inhibitory effects cannot be accounted for by induction of neutrophil death, or by changes in stimulatory receptor levels. Analysis of NADPH oxidase regulation using whole cell and cell-free systems suggests that the toxins do not exert direct effects on NADPH oxidase components, but rather act via their respective effects, inhibition of MAPK signaling (LTx), and elevation of intracellular cAMP (ETx), to inhibit upstream signaling components mediating NADPH oxidase assembly and/or activation. Our results demonstrate that anthrax toxins effectively suppress human neutrophil-mediated innate immunity by inhibiting their ability to generate superoxide for bacterial killing.</description><subject>Antigens, Bacterial - immunology</subject><subject>Bacillus anthracis</subject><subject>Bacillus anthracis - immunology</subject><subject>Bacillus anthracis - pathogenicity</subject><subject>Bacterial Toxins - immunology</subject><subject>Cell Survival - immunology</subject><subject>Cell-Free System - immunology</subject><subject>Cell-Free System - microbiology</subject><subject>Cyclic AMP - biosynthesis</subject><subject>Humans</subject><subject>Immunosuppressive Agents - immunology</subject><subject>NADPH Oxidases - antagonists & inhibitors</subject><subject>NADPH Oxidases - metabolism</subject><subject>Neutrophils - enzymology</subject><subject>Neutrophils - metabolism</subject><subject>Neutrophils - microbiology</subject><subject>p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors</subject><subject>p38 Mitogen-Activated Protein Kinases - metabolism</subject><subject>Protein Subunits - immunology</subject><subject>Reactive Oxygen Species - antagonists & inhibitors</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Receptors, Formyl Peptide - physiology</subject><subject>Signal Transduction - immunology</subject><subject>Superoxides - antagonists & inhibitors</subject><subject>Superoxides - metabolism</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>Up-Regulation - immunology</subject><subject>Virulence Factors - immunology</subject><issn>0022-1767</issn><issn>1550-6606</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpNkMtOwzAQRS0EoqXwBwhlhdikjJ3YTpalPFqpalmUteUkDnHlJCVOSPv3uGoRzGY0mnPv4iB0i2EcQhg_bnRZdlVtxpizMSZjTik_Q0NMKfiMATtHQwBCfPfmA3Rl7QYAGJDwEg0w4xSHQIZo_iRTbUxnPVm1ReMO663rna6sN68KnejWm3WlrLyl6tqm3hbaeMvJ8_vMW-10Jq3yJmmrv3W7v0YXuTRW3Zz2CH28vqynM3-xeptPJws_DVjc-jTME2BxGHGFmeJu8gArluYUIplAnMeZSmMlM06iNMlwRGTEowwTmQeERjIYoftj77apvzplW1FqmypjZKXqzgrMSRhEwBwYHsG0qa1tVC62jS5lsxcYxEGh-FXoMkxgIg4KXezu1N8lpcr-QidnDng4AoX-LHrdKGFLaYzDsej7_n_XDy0AfPw</recordid><startdate>20060615</startdate><enddate>20060615</enddate><creator>Crawford, Matthew A</creator><creator>Aylott, Caroline V</creator><creator>Bourdeau, Raymond W</creator><creator>Bokoch, Gary M</creator><general>Am Assoc Immnol</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>20060615</creationdate><title>Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity</title><author>Crawford, Matthew A ; Aylott, Caroline V ; Bourdeau, Raymond W ; Bokoch, Gary M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Antigens, Bacterial - immunology</topic><topic>Bacillus anthracis</topic><topic>Bacillus anthracis - immunology</topic><topic>Bacillus anthracis - pathogenicity</topic><topic>Bacterial Toxins - immunology</topic><topic>Cell Survival - immunology</topic><topic>Cell-Free System - immunology</topic><topic>Cell-Free System - microbiology</topic><topic>Cyclic AMP - biosynthesis</topic><topic>Humans</topic><topic>Immunosuppressive Agents - immunology</topic><topic>NADPH Oxidases - antagonists & inhibitors</topic><topic>NADPH Oxidases - metabolism</topic><topic>Neutrophils - enzymology</topic><topic>Neutrophils - metabolism</topic><topic>Neutrophils - microbiology</topic><topic>p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors</topic><topic>p38 Mitogen-Activated Protein Kinases - metabolism</topic><topic>Protein Subunits - immunology</topic><topic>Reactive Oxygen Species - antagonists & inhibitors</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Receptors, Formyl Peptide - physiology</topic><topic>Signal Transduction - immunology</topic><topic>Superoxides - antagonists & inhibitors</topic><topic>Superoxides - metabolism</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>Up-Regulation - immunology</topic><topic>Virulence Factors - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Crawford, Matthew A</creatorcontrib><creatorcontrib>Aylott, Caroline V</creatorcontrib><creatorcontrib>Bourdeau, Raymond W</creatorcontrib><creatorcontrib>Bokoch, Gary M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Journal of Immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Crawford, Matthew A</au><au>Aylott, Caroline V</au><au>Bourdeau, Raymond W</au><au>Bokoch, Gary M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity</atitle><jtitle>Journal of Immunology</jtitle><addtitle>J Immunol</addtitle><date>2006-06-15</date><risdate>2006</risdate><volume>176</volume><issue>12</issue><spage>7557</spage><epage>7565</epage><pages>7557-7565</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><eissn>1365-2567</eissn><abstract>Bacillus anthracis, the causative agent of anthrax, is a Gram-positive, spore-forming bacterium. B. anthracis virulence is ascribed mainly to a secreted tripartite AB-type toxin composed of three proteins designated protective Ag (PA), lethal factor, and edema factor. PA assembles with the enzymatic portions of the toxin, the metalloprotease lethal factor, and/or the adenylate cyclase edema factor, to generate lethal toxin (LTx) and edema toxin (ETx), respectively. These toxins enter cells through the interaction of PA with specific cell surface receptors. The anthrax toxins act to suppress innate immune responses and, given the importance of human neutrophils in innate immunity, they are likely relevant targets of the anthrax toxin. We have investigated in detail the effects of B. anthracis toxin on superoxide production by primary human neutrophils. Both LTx and ETx exhibit distinct inhibitory effects on fMLP (and C5a) receptor-mediated superoxide production, but have no effect on PMA nonreceptor-dependent superoxide production. These inhibitory effects cannot be accounted for by induction of neutrophil death, or by changes in stimulatory receptor levels. Analysis of NADPH oxidase regulation using whole cell and cell-free systems suggests that the toxins do not exert direct effects on NADPH oxidase components, but rather act via their respective effects, inhibition of MAPK signaling (LTx), and elevation of intracellular cAMP (ETx), to inhibit upstream signaling components mediating NADPH oxidase assembly and/or activation. Our results demonstrate that anthrax toxins effectively suppress human neutrophil-mediated innate immunity by inhibiting their ability to generate superoxide for bacterial killing.</abstract><cop>United States</cop><pub>Am Assoc Immnol</pub><pmid>16751402</pmid><doi>10.4049/jimmunol.176.12.7557</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1767 |
ispartof | Journal of Immunology, 2006-06, Vol.176 (12), p.7557-7565 |
issn | 0022-1767 1550-6606 1365-2567 |
language | eng |
recordid | cdi_proquest_miscellaneous_17243806 |
source | Wiley-Blackwell Read & Publish Collection; PubMed Central; EZB Electronic Journals Library |
subjects | Antigens, Bacterial - immunology Bacillus anthracis Bacillus anthracis - immunology Bacillus anthracis - pathogenicity Bacterial Toxins - immunology Cell Survival - immunology Cell-Free System - immunology Cell-Free System - microbiology Cyclic AMP - biosynthesis Humans Immunosuppressive Agents - immunology NADPH Oxidases - antagonists & inhibitors NADPH Oxidases - metabolism Neutrophils - enzymology Neutrophils - metabolism Neutrophils - microbiology p38 Mitogen-Activated Protein Kinases - antagonists & inhibitors p38 Mitogen-Activated Protein Kinases - metabolism Protein Subunits - immunology Reactive Oxygen Species - antagonists & inhibitors Reactive Oxygen Species - metabolism Receptors, Formyl Peptide - physiology Signal Transduction - immunology Superoxides - antagonists & inhibitors Superoxides - metabolism Tetradecanoylphorbol Acetate - pharmacology Up-Regulation - immunology Virulence Factors - immunology |
title | Bacillus anthracis Toxins Inhibit Human Neutrophil NADPH Oxidase Activity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A13%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bacillus%20anthracis%20Toxins%20Inhibit%20Human%20Neutrophil%20NADPH%20Oxidase%20Activity&rft.jtitle=Journal%20of%20Immunology&rft.au=Crawford,%20Matthew%20A&rft.date=2006-06-15&rft.volume=176&rft.issue=12&rft.spage=7557&rft.epage=7565&rft.pages=7557-7565&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.176.12.7557&rft_dat=%3Cproquest_cross%3E17243806%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c369t-54fb069487e16e7777f31e6cf508ab09f9dec9ead728cbd182a878d12af3258a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17243806&rft_id=info:pmid/16751402&rfr_iscdi=true |